Subscribe
shutterstock_2026137224_flowersandtraveling
Flowersandtraveling / Shutterstock.com
25 November 2021Americas

Pfizer claims employee stole COVID-19 vaccine documents

Pfizer is currently investigating a soon-to-be former employee who it believes has transferred more than 12,000 files, many of which contain confidential and trade secret information, to her personal devices and has repeatedly attempted to cover her tracks.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Pfizer signs antiviral COVID-19 licence with MPP
18 November 2021   Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID for low and middle-income countries.
Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
Pfizer signs antiviral COVID-19 licence with MPP
18 November 2021   Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID for low and middle-income countries.
Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

More on this story

Big Pharma
Pfizer signs antiviral COVID-19 licence with MPP
18 November 2021   Pfizer is the latest pharmaceutical company to sign a licensing agreement with the Medicines Patent Pool to help increase access to its COVID-19 oral antiviral treatment candidate PAXLOVID for low and middle-income countries.
Big Pharma
Sihuan sues equity group over Botox trade secrets
30 September 2021   A unit of Hong-Kong based Sihuan Pharmaceutical Holdings has filed a lawsuit in Beijing accusing private equity firm CBC Group of stealing trade secrets.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB